These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21454365)

  • 21. Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.
    Qiu N; Cao L; David V; Quarles LD; Xiao Z
    PLoS One; 2010 Dec; 5(12):e15240. PubMed ID: 21151991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice.
    Bivi N; Pacheco-Costa R; Brun LR; Murphy TR; Farlow NR; Robling AG; Bellido T; Plotkin LI
    J Orthop Res; 2013 Jul; 31(7):1075-81. PubMed ID: 23483620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.
    Alam I; Reilly AM; Alkhouli M; Gerard-O'Riley RL; Kasipathi C; Oakes DK; Wright WB; Acton D; McQueen AK; Patel B; Lim KE; Robling AG; Econs MJ
    Calcif Tissue Int; 2017 Apr; 100(4):361-373. PubMed ID: 28013361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.
    Windahl SH; Börjesson AE; Farman HH; Engdahl C; Movérare-Skrtic S; Sjögren K; Lagerquist MK; Kindblom JM; Koskela A; Tuukkanen J; Divieti Pajevic P; Feng JQ; Dahlman-Wright K; Antonson P; Gustafsson JÅ; Ohlsson C
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2294-9. PubMed ID: 23345419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.
    Kondoh S; Inoue K; Igarashi K; Sugizaki H; Shirode-Fukuda Y; Inoue E; Yu T; Takeuchi JK; Kanno J; Bonewald LF; Imai Y
    Bone; 2014 Mar; 60():68-77. PubMed ID: 24333171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-Catenin Haplo Insufficient Male Mice Do Not Lose Bone in Response to Hindlimb Unloading.
    Maurel DB; Duan P; Farr J; Cheng AL; Johnson ML; Bonewald LF
    PLoS One; 2016; 11(7):e0158381. PubMed ID: 27410430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
    McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
    J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression.
    Xiao Z; Zhang S; Mahlios J; Zhou G; Magenheimer BS; Guo D; Dallas SL; Maser R; Calvet JP; Bonewald L; Quarles LD
    J Biol Chem; 2006 Oct; 281(41):30884-95. PubMed ID: 16905538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
    Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
    J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional disruption of IGF-I gene in type 1α collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading.
    Kesavan C; Wergedal JE; Lau KH; Mohan S
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1191-7. PubMed ID: 21878662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading.
    Zhao L; Shim JW; Dodge TR; Robling AG; Yokota H
    Bone; 2013 May; 54(1):35-43. PubMed ID: 23356985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.
    Lau KW; Rundle CH; Zhou XD; Baylink DJ; Sheng MH
    Bone; 2016 Nov; 92():18-28. PubMed ID: 27519969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dentin matrix protein 1, a target molecule for Cbfa1 in bone, is a unique bone marker gene.
    Fen JQ; Zhang J; Dallas SL; Lu Y; Chen S; Tan X; Owen M; Harris SE; MacDougall M
    J Bone Miner Res; 2002 Oct; 17(10):1822-31. PubMed ID: 12369786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
    Zanotti S; Canalis E
    J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
    Xiong J; Almeida M; O'Brien CA
    Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.